Evidence map›Paper›PMID 40395204›Full record

ArticleDevelopment (Cambridge, England)2025

Transition paths across the epithelial-mesenchymal transition landscape are dictated by network logic.

Anupam Dey, Adam L MacLean

Abstract read
In one paragraph

Article in Development (Cambridge, England), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. AbioRxiv : the preprint server for biology · 2026
    Article
  2. Article
  3. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

2 authors.

Anupam DeyDepartment of Quantitative and Computational Biology, University of Southern California, Los Angeles, CA 90089, USA.ORCID 0000-0002-9071-8774
Adam L MacLeanDepartment of Quantitative and Computational Biology, University of Southern California, Los Angeles, CA 90089, USA.ORCID 0000-0003-0689-7907

Funding

Computational methods to predict gene regulatory network dynamics and cell state transitionsR35GM143019 · NIGMS · UNIVERSITY OF SOUTHERN CALIFORNIA · PI MACLEAN, ADAM L · 2021 to 2025
$2.1M
Foundation for the National Institutes of Health R35GM143019NIGMS NIH HHS R35 GM143019NIH HHS R35GM143019University of Southern California
6 · The paper itself

Abstract

During development and oncogenesis, cells transition reversibly from epithelial to mesenchymal states (epithelial-mesenchymal transition; EMT). Tristable EMT can be described by a three-node gene regulatory network in which multiple inputs regulate the transcription factor ZEB. In this network, and more generally, it is not known how to choose combinatorial network logic. Here, we discover that the choice of multiplicative (AND) versus additive (OR) network logic strongly affects EMT phenotypes and leads to opposing predictions regarding factors that control EMT transition paths. We show that strong inhibition of miR-200 destabilizes the epithelial state and initiates EMT for AND logic, in agreement with experimental data. Using single-cell data, stochastic simulations and perturbation analysis, we show how these results can be used to design experiments to infer EMT network logic in live cells. We go on to analyze networks controlling cell fate decisions during embryogenesis and show that, here too, logic changes cell fate landscapes upon perturbation in important ways. Our results stress the importance of considering logic in the construction of models of regulatory networks that govern cell fate decisions.

Indexed as

Epithelial-Mesenchymal TransitionGene Regulatory NetworksAnimalsGene Expression Regulation, DevelopmentalHumansMicroRNAsModels, BiologicalMicroRNAsEMTGene regulatory networkMathematical modelingMultistabilityNetwork logicTristability

Identifiers

PMID40395204
PMCPMC12188241

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.